Peer-influenced content. Sources you trust. No registration required. This is HCN.
GoodRx Health
Physicians should be aware of the evolving research regarding statins and dementia. Recent studies provide mixed evidence, with some suggesting a potential protective effect of statins against dementia, underscoring the necessity for individualized patient assessments.
Cardiology April 9th 2024
Mayo Clinic
Empower your patients with a multifaceted approach to cholesterol management, emphasizing the powerful combination of dietary adjustments, physical activity, and lifestyle changes alongside medical therapies.
All Specialties April 5th 2024
Consultant360
Stay updated on the USPSTF’s stance on lipid disorder screening in asymptomatic youth—a topic that directly impacts our strategies for early detection and intervention.
Endocrinology, Diabetes, Metabolism October 11th 2023
Annals of Internal Medicine
A recent Danish cohort study reveals that older adults (≥75 years) may experience a more pronounced LDL-C reduction with low- to moderate-intensity statins than their younger counterparts. This finding emphasizes the need to consider age when prescribing statin therapy.
Cardiology August 9th 2023
The New England Journal of Medicine
Bempedoic acid is currently approved for two patient subgroups. This 3-year, double-blind, randomized, placebo-controlled trial examined cholesterol-lowering and CV protective effects in a broader population of approximately 14,000 patients with elevated cholesterol who were unable or unwilling to take statins. The drug was 21% more effective than placebo at reducing LDL in this trial. There was a small but significant reduction in primary events of CV-related death, MI, stroke, or coronary revascularization.
Cardiology March 15th 2023
MDLinx
This summary of a January 2023 JACC article highlights the study finding that rosuvastatin was “vastly superior to… any of the six supplements studied in the trial.” The study compared rosuvastatin to cinnamon, garlic, turmeric, red yeast rice, fish oil, and plant sterols. Rosuvastatin yielded a reduction in cholesterol of nearly 38 percent in just 28 days. The supplements had little to no effect but were significantly more costly than the statin.
Cardiology February 8th 2023